Live feed07:29:00·1365dPRReleasevia QuantisnowVertex and CRISPR Therapeutics Announce Global exa-cel Regulatory Submissions for Sickle Cell Disease and Beta Thalassemia in 2022ByQuantisnow·Wall Street's wire, on your screen.CRSP· CRISPR Therapeutics AGVRTX· Vertex Pharmaceuticals IncorporatedHealth Care
